Consolidated Statements of Operations and Comprehensive Loss - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Operating expenses
General and administrative	$ 6,453,505	$ 8,852,021
Research and development	2,841,272	7,252,437
Depreciation and amortization	337,489	343,982
Total operating expenses	9,632,266	16,448,440
Loss from operations	(9,632,266)	(16,448,440)
Other income (expense)
Inducement expense, net		(1,848,235)
Change in fair value of warrant liabilities	24,370	94,396
Change in fair value of investment option liability	21,620	208,752
Change in fair value of derivative liability		727,000
Other income	20,000
Interest income, net	219	3,708
Total other income (expense)	66,209	(814,379)
Net loss before income taxes	(9,566,057)	(17,262,819)
Income tax expense	(8,930)	(28,913)
Net loss	(9,574,987)	(17,291,732)
Less preferred dividends attributable to non-controlling interest		19,041
Less deemed dividends attributable to accretion of embedded derivative at redemption value		147,988
Net loss attributable to shareholders	(9,574,987)	(17,458,761)
Other comprehensive loss
Foreign currency translation	(24,768)	(33,015)
Comprehensive loss	$ (9,599,755)	$ (17,491,776)
Net loss per share - basic	$ (19.04)	$ (121.29)
Net loss per share - diluted	$ (19.04)	$ (121.29)
Weighted average shares outstanding, basic	502,900	143,938
Weighted average shares outstanding, diluted	502,900	143,938